Clinical Trial Update: A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 study of ALKS 3831 in adults with schizophrenia and alcohol use disorder has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Schizophrenia

Drugs mentioned

• ALKS 3831

Snippet

Sponsor: Alkermes, Inc. | Conditions: Schizophrenia, Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-10-08